Literature DB >> 35384563

Terson syndrome in reverse: intraventricular haemorrhage following primary intraocular haemorrhage.

Ashwin Kumaria1, Anna M Gruener2, Robert K Lenthall3, Harshal A Ingale4.   

Abstract

Terson syndrome (TS) describes the presence of intraocular haemorrhage in patients with intracranial haemorrhage or traumatic brain injury. The aetiology of TS is controversial as an anatomical conduit between the vitreous humour and subarachnoid space remains contested. We herewith present a case of primary vitreous haemorrhage with secondary intracranial extension into the ventricles. Cranial CT demonstrates blood within the left optic nerve and chiasm but not within the subarachnoid space. This unusual phenomenon, which has not been reported before, may be described as 'Terson syndrome in reverse'. We explore mechanisms by which blood within the globe may track into the ventricular system, contextualising recent advances in the understanding of ocular-intracranial fluid transport.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Glymphatic; Glymphatic reflux theory; Intraventricular haemorrhage; Terson syndrome; Vitreous haemorrhage

Mesh:

Year:  2022        PMID: 35384563     DOI: 10.1007/s10072-022-06053-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

Review 1.  Pathophysiology of retinal lymphoma.

Authors:  Sarah E Coupland; Chi Chao Chan; Justine Smith
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

2.  Insights in primary central nervous system lymphoma: a role for glymphatics?

Authors:  Ashwin Kumaria
Journal:  Brain Tumor Pathol       Date:  2021-09-17       Impact factor: 3.298

Review 3.  An explanation for Terson syndrome at last: the glymphatic reflux theory.

Authors:  Ashwin Kumaria; Anna M Gruener; Graham R Dow; Stuart J Smith; Donald C Macarthur; Harshal A Ingale
Journal:  J Neurol       Date:  2021-06-25       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.